July 15 (Reuters) - Camurus AB CAMX.ST :
* Q2 TOTAL REVENUES AMOUNTED TO SEK 227 (138) MILLION
* Q2 OPERATING RESULT WAS SEK 7 (-60) MILLION
* OUR POSITIVE DEVELOPMENT CONTINUED DURING Q2 WITH
INCREASING
BUVIDAL PATIENT NUMBERS, IMPROVED FINANCIAL RESULT, AND PROGRESS
IN OUR REGISTRATION AND PHASE 3 PROGRAMS IN CHRONIC PAIN AND
RARE DISEASES
* STRONG, DOUBLE-DIGIT GROWTH OF BUVIDAL SALES RESULTED IN A
HISTORIC FIRST PROFITABLE QUARTER, IMPROVED CASH POSITION, AND A
RAISED FULL-YEAR RESULT GUIDANCE
* WE ARE WELL POSITIONED TO SUCCESSFULLY DELIVER ON OUR
GOALS FOR
YEAR AND LONG-TERM STRATEGY
Source text for Eikon: ID:nWkr3K90tc
Further company coverage: CAMX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))